Beijing Institute of Dental Research, Beijing Stomatological Hospital, Capital Medical University, Beijing, China.
Department of Dental Implant Center, School of Stomatology, Beijing Stomatological Hospital, Capital Medical University, Beijing, China.
Oral Dis. 2023 Mar;29(2):445-457. doi: 10.1111/odi.13922. Epub 2021 Jun 7.
Natural autoantibodies serve as an important anti-tumorigenic component in the body. This study was thus designed to investigate whether circulating natural IgG autoantibodies against a cluster of differentiation 47 (CD47) could exert inhibitory effects on oral squamous cell carcinoma (OSCC).
The expression levels of 13 tumor-targeted genes in three OSCC cell lines were analyzed by qPCR, and CD47 expression in OSCC tissues was also verified with IHC staining. An in-house ELISA was performed to analyze circulating anti-CD47 IgG levels in control subjects, oral benign tumor, and OSCC patients, and to detect anti-CD47 IgG-abundant plasma. Three OSCC cell lines were treated with anti-CD47 IgG-abundant and -deficient plasma, respectively, followed by the analysis of cell proliferation, apoptosis, and invasion/metastasis.
The CD47 gene showed the highest expression among 13 genes detected in three OSCC cell lines; its expression was significantly higher in OSCC tissues than adjacent tissues. Plasma anti-CD47 IgG levels showed the differences between control subjects, oral benign tumor, and OSCC patients. Anti-CD47 IgG-abundant plasma could evidently reduce cell viability via suppressing p-AKT expression and inducing cell apoptosis and inhibit the invasion of all three OSCC cell lines.
Natural autoantibodies against CD47 may be a potential agent for OSCC immunotherapy.
天然自身抗体是机体重要的抗肿瘤成分。本研究旨在探讨针对分化簇 47(CD47)的循环天然 IgG 自身抗体是否对口腔鳞状细胞癌(OSCC)具有抑制作用。
通过 qPCR 分析三种 OSCC 细胞系中 13 个肿瘤靶向基因的表达水平,并通过免疫组化染色验证 OSCC 组织中 CD47 的表达。采用内部 ELISA 分析对照受试者、口腔良性肿瘤和 OSCC 患者的循环抗 CD47 IgG 水平,并检测抗 CD47 IgG 丰富的血浆。用抗 CD47 IgG 丰富和缺乏的血浆分别处理三种 OSCC 细胞系,然后分析细胞增殖、凋亡和侵袭/转移。
在三种 OSCC 细胞系中,CD47 基因在检测到的 13 个基因中表达最高;其在 OSCC 组织中的表达明显高于相邻组织。血浆抗 CD47 IgG 水平在对照受试者、口腔良性肿瘤和 OSCC 患者之间存在差异。抗 CD47 IgG 丰富的血浆可通过抑制 p-AKT 表达和诱导细胞凋亡来显著降低细胞活力,并抑制三种 OSCC 细胞系的侵袭。
针对 CD47 的天然自身抗体可能是 OSCC 免疫治疗的潜在药物。